Role of saxagliptin as monotherapy or adjunct therapy in the treatment of type 2 diabetes

Morali D Sharma

doi:10.2147/TCRM.S7679

open access to scientific and medical research

Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Review

Role of saxagliptin as monotherapy or adjunct therapy in the treatment of type 2 diabetes

Total article views		HTML views	PDF downloads	Totals
13,089	Dovepress*	13,089+	2,425	15,514
13,089	Totals	13,089	2,425	15,514
*Since 10 May 2010 +Since July 2016

View citations on Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.